Gossamer Bio (GOSS) Total Debt (2019 - 2026)

Gossamer Bio has reported Total Debt for 7 years, with the latest figure at $36.1 million in Q2 2026.

• On a quarterly basis, Total Debt changed N/A year-over-year to $36.1 million in Q2 2026; TTM through Jun 2026 was $36.1 million, a N/A change from a year earlier, with the FY2023 full-year figure at $12.4 million, down 47.35% from the prior year.
• Total Debt was $36.1 million for Q2 2026 at Gossamer Bio, up from $9.6 million in the prior quarter.
• The five-year high for Total Debt was $36.1 million in Q2 2026, with the low at $9.6 million in Q1 2024.
• Average Total Debt over 4 years is $19.8 million, with a median of $17.8 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Total Debt grew 2.78% in 2023, then tumbled 53.97% in 2024.
• Over 4 years, Total Debt stood at $23.6 million in 2022, then sank by 47.35% to $12.4 million in 2023, then dropped by 22.84% to $9.6 million in 2024, then soared by 276.94% to $36.1 million in 2026.
• The last three Total Debt figures came in at $36.1 million (Q2 2026), $9.6 million (Q1 2024), and $12.4 million (Q4 2023), per Business Quant data.